Barbara Seroczyńska

599 total citations
20 papers, 465 citations indexed

About

Barbara Seroczyńska is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Barbara Seroczyńska has authored 20 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Barbara Seroczyńska's work include Cancer Cells and Metastasis (9 papers), HER2/EGFR in Cancer Research (4 papers) and Circadian rhythm and melatonin (3 papers). Barbara Seroczyńska is often cited by papers focused on Cancer Cells and Metastasis (9 papers), HER2/EGFR in Cancer Research (4 papers) and Circadian rhythm and melatonin (3 papers). Barbara Seroczyńska collaborates with scholars based in Poland, Norway and Germany. Barbara Seroczyńska's co-authors include Jarosław Skokowski, Anna J. Żaczek, Marzena Wełnicka-Jaśkiewicz, Aleksandra Markiewicz, Jolanta Szade, Edyta Wieczorek, Leszek Kalinowski, Edyta Reszka, Ewa Jabłońska and Wojciech Biernat and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Annals of Oncology.

In The Last Decade

Barbara Seroczyńska

20 papers receiving 459 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Seroczyńska Poland 11 247 154 138 75 63 20 465
Céline Delierneux Belgium 13 110 0.4× 270 1.8× 76 0.6× 55 0.7× 25 0.4× 23 599
Huiyuan Zheng Sweden 10 58 0.2× 234 1.5× 73 0.5× 58 0.8× 7 0.1× 18 405
Thomas Griesbacher Austria 15 82 0.3× 256 1.7× 36 0.3× 26 0.3× 24 0.4× 38 714
Tomasz B. Owczarek Poland 12 188 0.8× 268 1.7× 95 0.7× 46 0.6× 51 0.8× 18 533
Masakazu Souda Japan 13 234 0.9× 139 0.9× 149 1.1× 58 0.8× 12 0.2× 30 501
Claus W. Hann von Weyhern Germany 7 87 0.4× 156 1.0× 76 0.6× 23 0.3× 90 1.4× 7 552
Tie Sun China 10 85 0.3× 178 1.2× 156 1.1× 36 0.5× 24 0.4× 24 397
Muhlis Akman Italy 10 105 0.4× 202 1.3× 134 1.0× 53 0.7× 32 0.5× 14 453
Kris Mann United States 7 48 0.2× 209 1.4× 126 0.9× 50 0.7× 6 0.1× 10 635
Sonja Matt Germany 7 128 0.5× 259 1.7× 54 0.4× 37 0.5× 9 0.1× 7 434

Countries citing papers authored by Barbara Seroczyńska

Since Specialization
Citations

This map shows the geographic impact of Barbara Seroczyńska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Seroczyńska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Seroczyńska more than expected).

Fields of papers citing papers by Barbara Seroczyńska

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Seroczyńska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Seroczyńska. The network helps show where Barbara Seroczyńska may publish in the future.

Co-authorship network of co-authors of Barbara Seroczyńska

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Seroczyńska. A scholar is included among the top collaborators of Barbara Seroczyńska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Seroczyńska. Barbara Seroczyńska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jabłońska, Ewa, Edyta Wieczorek, Barbara Seroczyńska, et al.. (2019). A different methylation profile of circadian genes promoter in breast cancer patients according to clinicopathological features. Chronobiology International. 36(8). 1103–1114. 10 indexed citations
2.
Markiewicz, Aleksandra, Jarosław Skokowski, Barbara Seroczyńska, et al.. (2019). Spectrum of Epithelial-Mesenchymal Transition Phenotypes in Circulating Tumour Cells from Early Breast Cancer Patients. Cancers. 11(1). 59–59. 42 indexed citations
3.
Jabłońska, Ewa, Edyta Wieczorek, Beata Pepłońska, et al.. (2019). Circadian Gene Polymorphisms Associated with Breast Cancer Susceptibility. International Journal of Molecular Sciences. 20(22). 5704–5704. 22 indexed citations
4.
Zieliński, Maciej, Dariusz Gąsecki, Kamil Kowalczyk, et al.. (2018). CD271+, CXCR7+, CXCR4+, and CD133+ Stem/Progenitor Cells and Clinical Characteristics of Acute Ischemic Stroke Patients. NeuroMolecular Medicine. 20(3). 301–311. 7 indexed citations
5.
Jabłońska, Ewa, Edyta Wieczorek, Barbara Seroczyńska, et al.. (2018). Altered circadian genes expression in breast cancer tissue according to the clinical characteristics. PLoS ONE. 13(6). e0199622–e0199622. 51 indexed citations
6.
Markiewicz, Aleksandra, Jolanta Szade, Hanna Majewska, et al.. (2018). Aggressive Phenotype of Cells Disseminated via Hematogenous and Lymphatic Route in Breast Cancer Patients. Translational Oncology. 11(3). 722–731. 18 indexed citations
7.
Markiewicz, Aleksandra, Jolanta Szade, Hanna Majewska, et al.. (2017). Expression of stem cell and mesenchymal markers in circulating tumor cells is associated with poor prognosis of early breast cancer patients. Annals of Oncology. 28. vii32–vii32. 1 indexed citations
8.
Jabłońska, Ewa, Katarzyna Socha, Edyta Reszka, et al.. (2017). Cadmium, arsenic, selenium and iron– Implications for tumor progression in breast cancer. Environmental Toxicology and Pharmacology. 53. 151–157. 60 indexed citations
9.
Czapiewski, Piotr, Marzena Wełnicka-Jaśkiewicz, Barbara Seroczyńska, et al.. (2015). CD99 correlates with low cyclin D1, high topoisomerase 2 status and triple negative molecular phenotype but is prognostically irrelevant in breast carcinoma. Polish Journal of Pathology. 3(3). 269–275. 4 indexed citations
10.
Seroczyńska, Barbara, et al.. (2015). Differentiation of high‐risk stage I and II colon tumors based on evaluation of CAV1 gene expression. Journal of Surgical Oncology. 112(4). 408–414. 7 indexed citations
11.
Markiewicz, Aleksandra, Magdalena Książkiewicz, Marzena Wełnicka-Jaśkiewicz, et al.. (2014). Mesenchymal Phenotype of CTC-Enriched Blood Fraction and Lymph Node Metastasis Formation Potential. PLoS ONE. 9(4). e93901–e93901. 38 indexed citations
12.
Miękus, Natalia, Ilona Olędzka, Alina Plenis, et al.. (2014). Gel electrophoretic separation of proteins from cultured neuroendocrine tumor cell lines. Molecular Medicine Reports. 11(2). 1407–1415. 8 indexed citations
13.
Markiewicz, Aleksandra, Marzena Wełnicka-Jaśkiewicz, Barbara Seroczyńska, et al.. (2014). Epithelial-mesenchymal transition markers in lymph node metastases and primary breast tumors - relation to dissemination and proliferation.. PubMed. 6(6). 793–808. 23 indexed citations
14.
Plenis, Alina, Natalia Miękus, Ilona Olędzka, et al.. (2013). Chemometric Evaluation of Urinary Steroid Hormone Levels as Potential Biomarkers of Neuroendocrine Tumors. Molecules. 18(10). 12857–12876. 5 indexed citations
15.
Markiewicz, Aleksandra, Magdalena Książkiewicz, Barbara Seroczyńska, et al.. (2013). Heterogeneity of Mesenchymal Markers Expression—Molecular Profiles of Cancer Cells Disseminated by Lymphatic and Hematogenous Routes in Breast Cancer. Cancers. 5(4). 1485–1503. 8 indexed citations
16.
Supernat, Anna, Aleksandra Markiewicz, Aleksandra Sejda, et al.. (2012). 83P Correlation of C-Myc with Epithelial-Mesenchymal Transition Phenotype. Annals of Oncology. 23. ii38–ii38. 1 indexed citations
17.
Żaczek, Anna J., Aleksandra Markiewicz, Anna Supernat, et al.. (2012). Prognostic Value of TOP2A Gene Amplification and Chromosome 17 Polysomy in Early Breast Cancer. Pathology & Oncology Research. 18(4). 885–894. 22 indexed citations
18.
Markiewicz, Aleksandra, Tomasz Ahrends, Marzena Wełnicka-Jaśkiewicz, et al.. (2012). Expression of epithelial to mesenchymal transition-related markers in lymph node metastases as a surrogate for primary tumor metastatic potential in breast cancer. Journal of Translational Medicine. 10(1). 226–226. 44 indexed citations
19.
Żaczek, Anna J., Aleksandra Markiewicz, Barbara Seroczyńska, et al.. (2012). Prognostic Significance of TOP2A Gene Dosage in HER-2-Negative Breast Cancer. The Oncologist. 17(10). 1246–1255. 22 indexed citations
20.
Supernat, Anna, Aleksandra Markiewicz, Marzena Wełnicka-Jaśkiewicz, et al.. (2011). CD73 Expression as a Potential Marker of Good Prognosis in Breast Carcinoma. Applied immunohistochemistry & molecular morphology. 20(2). 103–107. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Céline Delierneux Breakdown of academic impact, for papers by Huiyuan Zheng Breakdown of academic impact, for papers by Thomas Griesbacher Breakdown of academic impact, for papers by Tomasz B. Owczarek Breakdown of academic impact, for papers by Masakazu Souda Breakdown of academic impact, for papers by Claus W. Hann von Weyhern Breakdown of academic impact, for papers by Tie Sun Breakdown of academic impact, for papers by Muhlis Akman Breakdown of academic impact, for papers by Kris Mann Breakdown of academic impact, for papers by Sonja Matt
Rankless by CCL
2026